Cyclopharm Ltd Total Assets

Latest as of June 2026: AU$49.68 Million AUD ≈ $35.15 Million USD

Cyclopharm Ltd total assets. Based on the latest financial reports, Cyclopharm Ltd (CYC) holds total assets worth AU$49.68 Million AUD (≈ $35.15 Million USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Cyclopharm Ltd (CYC) market capitalisation for the company's overall valuation and market capitalisation.

Total Assets of Cyclopharm Ltd (2005–2025)

Total assets of Cyclopharm Ltd from 2005 to 2025. This chart illustrates how Cyclopharm Ltd's total assets have evolved over time, based on quarterly financial data. See CYC stock price and chart for real-time trading data and today's change.

Cyclopharm Ltd - Asset Composition Analysis

Cyclopharm Ltd Total Assets Breakdown (December 2025)

Cyclopharm Ltd total assets breakdown as of December 2025. Cyclopharm Ltd's total assets of AU$49.68 Million consist of 61.7% current assets and 38.3% non-current assets.

Asset Category	Amount (AUD)	% of Total Assets
Cash & Equivalents	AU$0.00	14.4%
Accounts Receivable	AU$8.59 Million	18.6%
Inventory	AU$11.43 Million	24.8%
Property, Plant & Equipment	AU$13.40 Million	29.1%
Intangible Assets	AU$1.70 Million	3.7%
Goodwill	AU$974.61K	2.1%

Asset Composition Trend (2005–2025)

This chart illustrates how Cyclopharm Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore Cyclopharm Ltd working capital to net assets to assess how much short-term liquidity the company maintains relative to its equity base.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Cyclopharm Ltd's current assets represent 61.7% of total assets in 2025, an increase from 61.2% in 2005.
Cash Position: Cash and equivalents constituted 14.4% of total assets in 2025, down from 41.2% in 2005.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 5.0% of total assets, a decrease from 31.0% in 2005.
Asset Diversification: The largest asset category is property, plant & equipment at 29.1% of total assets.

Cyclopharm Ltd Competitors by Total Assets

Key competitors of Cyclopharm Ltd based on total assets are shown below.

Company	Country	Total Assets
Demant A/S CO:DEMANT	Denmark	Dkr39.07 Billion
Shanghai Sanyou Medical Co Ltd SHG:688085	China	CN¥2.34 Billion
CareRay Digital Medical Technology Co Ltd SHG:688607	China	CN¥988.48 Million
PULSION Medical Systems SE MU:PUS	Germany	€35.15 Million
Cleo Diagnostics Ltd AU:COV	Australia	AU$9.96 Million
Memphasys Ltd AU:MEM	Australia	AU$10.45 Million
Cochlear Ltd AU:COH	Australia	AU$2.83 Billion
4DMEDICAL Ltd AU:4DX	Australia	AU$139.55 Million

Cyclopharm Ltd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	3.37	3.19	9.01
Quick Ratio	2.17	1.94	7.93
Cash Ratio	0.00	0.00	0.00
Working Capital	AU$23.86 Million	AU$24.90 Million	AU$37.57 Million

Cyclopharm Ltd - Advanced Valuation Insights

This section examines the relationship between Cyclopharm Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	1.85
Latest Market Cap to Assets Ratio	0.88
Asset Growth Rate (YoY)	-25.8%
Total Assets	AU$46.10 Million
Market Capitalization	$40.48 Million USD

Valuation Analysis

Near Book Valuation: The market values Cyclopharm Ltd's assets close to their book value (0.88x), suggesting investors view the company's assets at approximately fair value.

Significant Asset Reduction: Cyclopharm Ltd's assets decreased by 25.8% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for Cyclopharm Ltd (2005–2025)

The table below shows the annual total assets of Cyclopharm Ltd from 2005 to 2025.

Year	Total Assets	Change
2025-12-31	AU$46.10 Million ≈ $32.62 Million	-25.80%
2024-12-31	AU$62.13 Million ≈ $43.96 Million	+35.31%
2023-12-31	AU$45.91 Million ≈ $32.49 Million	-7.32%
2022-12-31	AU$49.54 Million ≈ $35.05 Million	-11.12%
2021-12-31	AU$55.74 Million ≈ $39.44 Million	+97.14%
2020-12-31	AU$28.28 Million ≈ $20.01 Million	-13.08%
2019-12-31	AU$32.53 Million ≈ $23.02 Million	+38.20%
2018-12-31	AU$23.54 Million ≈ $16.65 Million	+0.68%
2017-12-31	AU$23.38 Million ≈ $16.54 Million	+42.41%
2016-12-31	AU$16.41 Million ≈ $11.61 Million	-0.76%
2015-12-31	AU$16.54 Million ≈ $11.70 Million	+50.90%
2014-12-31	AU$10.96 Million ≈ $7.76 Million	+21.65%
2013-12-31	AU$9.01 Million ≈ $6.38 Million	-58.39%
2012-12-31	AU$21.66 Million ≈ $15.32 Million	+1.71%
2011-12-31	AU$21.29 Million ≈ $15.07 Million	-3.83%
2010-12-31	AU$22.14 Million ≈ $15.67 Million	+12.71%
2009-12-31	AU$19.64 Million ≈ $13.90 Million	+5.73%
2008-12-31	AU$18.58 Million ≈ $13.15 Million	+69.25%
2007-12-31	AU$10.98 Million ≈ $7.77 Million	+21.15%
2006-12-31	AU$9.06 Million ≈ $6.41 Million	-56.84%
2005-12-31	AU$20.99 Million ≈ $14.86 Million	--

About Cyclopharm Ltd

AU:CYC Australia Medical Devices

Market Cap

$40.48 Million

AU$57.21 Million AUD

Market Cap Rank

#22425 Global

#793 in Australia

Share Price

AU$0.46

Change (1 day)

-2.15%

52-Week Range

AU$0.36 - AU$1.23

All Time High

AU$3.26